Control group n (%) or mean (SD) | Pandemic group n (%) or mean (SD) | p-value | Total | |
---|---|---|---|---|
Total (n) | 82 (45.1) | 100 (54.9) | 182 (100.0) | |
Sex | ||||
Male | 32 (39.0) | 46 (46.0) | 0.344 | 78 (42.9) |
Female | 50 (61.0) | 54 (54.0) | 104 (57.1) | |
Age; years | 54.4 (19.0) | 55.9 (17.5) | 0.606 | 55.2 (18.2) |
Number of elderly patients; > 65 yo | 28 (34.1) | 34 (34.0) | 0.983 | 62 (34.1) |
BMI; kg/m2 | 29.7 (6.3) | 29.9 (6.9) | 0.971 | 29.8 (6.6) |
ASA | ||||
1 | 4 (4.9) | 8 (8.0) | 0.637 | 12 (6.6) |
2 | 56 (68.3) | 63 (63.0) | 119 (65.4) | |
3 | 22 (26.8) | 28 (28.0) | 50 (27.5) | |
4 | 0 (0.0) | 1 (1.0) | 1 (0.5) | |
Previous abdominal surgery | 26 (31.7) | 25 (25.0) | 0.316 | 51 (28.0) |
Cholecystitis | 20 (24.4) | 37 (37.0) | 0.068 | 57 (31.3) |
Gangrenous cholecystitis | 2 (2.4) | 7 (7.0) | 0.188 | 9 (4.9) |
Biliary pancreatitis | 12 (14.6) | 19 (19.0) | 0.436 | 31 (17.0) |
Choledocholithiasis | 27 (32.9) | 26 (26.0) | 0.306 | 53 (29.1) |
ERCP with SE | 18 (22.0) | 18 (18.0) | 0.506 | 36 (19.8) |
ERCP with BSI | 1 (1.2) | 4 (4.0) | 0.380 | 5 (2.7) |